Teladoc Health said it granted new Chief Financial Officer Michael Grasher restricted stock units covering 239,616 shares and performance stock units with a target of 239,616 shares, with as many as 479,232 shares potentially earned. The awards took effect Sept. 1, 2026, when Grasher began his employment. The restricted stock units vest over several years based on continued service, while the performance awards depend on Teladoc Health’s adjusted EBITDA for 2026 and actual compound annual revenue growth from 2026 through 2028. The awards were approved by the company’s Compensation Committee and issued under its 2023 Employment Inducement Incentive Award Plan pursuant to New York Stock Exchange Rule 303A.08.